匯創達(300909.SZ):成功研發生產了超小型防水輕觸開關
格隆匯12月27日丨匯創達(300909.SZ)在投資者互動平台表示,公司主要從事導光結構件及組件、信號傳輸元器件及組件的研發、設計、生產和銷售,主要產品包括背光模組、精密按鍵開關及連接器三大類,在導光結構件及組件領域,公司的競爭對手包括我國台灣地區的茂林光電、頎茂光電以及大陸地區的蘇大維格等企業;在精密按鍵開關領域,公司競爭對手主要有日本的阿爾卑斯、松下電器、西鐵城等企業;在連接器領域,公司競爭對手主要有長盈精密、電連技術、徠木股份等企業。公司成功研發生產了超小型防水輕觸開關,突破了國外超小型防水輕觸開關的技術壁壘,實現了國內相關產品的進口替代,公司產品情況請關注公司後續披露的定期報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.